Alpha Signal Monitor - Daily Market Briefing | July 10, 2026
Daily Market Research Report
July 10, 2026
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM
This report is generated using advanced AI research capabilities with real-time market data access.
Gold ETFs: Institutional Outlook (as of July 10, 2026)
Trading Idea: Buy (accumulate on weakness) Rationale (TL;DR): Despite a June drawdown that briefly took spot below $4,000/oz, most major houses still see year‑end 2026 gold between ~$4,800–$6,000 with central‑bank demand and eventual Fed easing as supports; we favor gradually adding GLD/IAU/BAR on dips while acknowledging near‑term policy and USD risks. (fidelity.com)
Hawkish Fed repricing under new Chair Kevin Warsh lifted real yields and the USD in June, pressuring gold; ETF/futures demand softened, but central‑bank buying remains a structural backstop. If policy tightness peaks and cuts are pushed into 2027, the medium‑term path still points higher from current levels. (fixedincome.fidelity.com)
Key Drivers - Policy path: timing of the first Fed cuts vs. risk of additional 2026 hikes. - USD and real yields: inverse correlation to gold re‑asserted in 2026. - Central‑bank purchases: continued reserve diversification supports prices. - ETF flows: resumed buying would add incremental demand; recent softness is a headwind. - Geopolitics/fiscal risk: episodes of stress can lift precautionary demand.
| Institution | Stance | Price View | Key Evidence | Last Update | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Constructive but tactically cautious | End‑2026 gold target cut to $4,900/oz (from $5,400) on June 19, 2026. | GS trimmed its 2026 target citing a more hawkish Fed path and softer ETF demand, but kept a structurally positive view anchored in central‑bank diversification. | 2026-06-19 | Reuters summary and Benzinga write‑up of GS note. (fixedincome.fidelity.com) |
| Morgan Stanley | Bullish (H2 recovery) | $5,200/oz in H2‑2026 (bull case previously up to ~$5,700). | MS argues gold’s safe‑haven role was overshadowed by policy; expects central banks/ETFs to resume purchases with the Fed on hold through 2026, supporting a rebound. | 2026-05-05 | Morgan Stanley Insights: “Is Gold Still a Safe Haven?” (morganstanley.com) |
| JP Morgan | Bullish (longer‑term) | Sees ~$6,000/oz by Q4‑2026 (avg), with $6,300/oz possible into 2027; near‑term average trimmed to ~$5,243/oz in recent update. | JPM’s Global Commodities Strategy highlights resilient official demand and potential for prices to push toward $6k by year‑end; later note trimmed averages but kept a bullish base case. | 2026-06-10 | J.P. Morgan Global Research pages and follow‑up coverage on forecast trim. (jpmorgan.com) |
| Bank of America | Positive long‑term, near‑term tempered | Cuts 2026 average to ~$4,360/oz (Jul 8, 2026) but still sees a path to ~$5,000 once tightening cycle ends. | BofA reduced its 2026 average on a hawkish Fed shift yet reiterated upside once policy eases; earlier in 2026 it flagged potential overshoots during tight‑supply episodes. | 2026-07-08 | Reuters/MarketScreener roundup; prior BofA Global Research outlooks. (ca.marketscreener.com) |
| Citigroup | Neutral to cautious (near term) | 0–3M target cut to $4,000/oz (Jun 9, 2026); 6–12M target ~$4,500/oz contingent on a dovish Fed pivot or renewed shocks. | Citi cites stabilizing real yields, stronger USD bias and moderating safe‑haven/ETF demand for limited near‑term upside. | 2026-06-09 | Kitco summary of Citi Research note. (kitco.com) |
| UBS | Positive; trimmed | Year‑end 2026 target reduced to $5,500/oz (from $5,900) on May 27, 2026; sees support from later‑year easing and central‑bank buying. | UBS CIO notes softer ETF/futures demand and a negative gold–real‑yield linkage (-0.6 correlation), but expects momentum to rebuild as tightening fears fade. | 2026-05-27 | UBS CIO Daily and related coverage. (ubs.com) |
| HSBC | Constructive but lowered averages | 2026 average cut to ~$4,560/oz (Jul 9, 2026); earlier saw potential to test ~$5,000 in H1‑2026 amid geopolitical/fiscal risks. | HSBC cites a hawkish Fed tilt and stronger USD for the downgrade, while maintaining a positive posture on medium‑term drivers (official demand, diversification). | 2026-07-09 | Reuters recaps and HSBC AM/Private Banking materials. (ca.investing.com) |
| Deutsche Bank | Neutral to cautious (near term) | Revised base case ~$4,800/oz in Q4‑2026 (risk case ~$3,800); prior early‑2026 commentary discussed potential to $6,000/oz. | DB cut its outlook as Fed repricing lifted real yields and sapped investment demand (ETF selling, low futures OI); still sees EM central‑bank buying as supportive. | 2026-06-23 | Investing.com/Reuters report on DB revision; earlier DB comments. (uk.investing.com) |
Risk Considerations - More-hawkish‑than‑expected Fed path or sustained USD strength keeps real yields high and caps gold rallies. - Prolonged ETF outflows/futures de‑risking extend technical weakness. - A sharper slowdown in EM jewelry/coin demand (e.g., India tax changes) weighs on physical markets. - Central‑bank demand undershoots expectations. - Rapid disinflation and risk‑on broadly reduce hedging demand.
Implementation: scale into GLD/IAU/BAR over the next 1–3 months; size positions assuming near‑term chop around policy headlines, with scope to add on weakness if Fed‑hike odds fade and ETF flows stabilize. We would reassess if the Fed signals multiple 2026 hikes or if official‑sector demand slows materially. (fixedincome.fidelity.com)
Stock Ratings — Street targets and ratings from GS, MS, JPM, BAC, C, WFC (as of July 10, 2026)
Data compiled from each stock’s MarketBeat analyst-forecast page; per-bank entries list the latest action visible on those pages within the last 12–18 months, with targets when provided. Sources: Apple (AAPL), Microsoft (MSFT), Alphabet Class A (GOOGL), Amazon (AMZN), NVIDIA (NVDA), Meta (META), Tesla (TSLA), Broadcom (AVGO), and Taiwan Semiconductor (TSM).
AAPL - Apple Inc.
Most of the six banks are Buy/Overweight; Bank of America most recently cut to Hold with a lower target. Consensus leans Moderate Buy across this group.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | - | 2026-03-02 | Reiterated rating. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Morgan Stanley | Overweight | - | 2026-06-22 | Reiterated rating. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| JP Morgan | Overweight | $325 | 2026-01-26 | Boost target $315 → $325. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Bank of America | Hold | $315 | 2026-06-18 | Downgrade Outperform → Hold. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Citigroup | Buy | - | 2026-05-14 | Reiterated rating. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Wells Fargo | Overweight | $310 | 2026-05-01 | Boost target $300 → $310. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
Consensus View - Rating: Moderate Buy, Target Price: $316.67 - 5 Buy/Overweight vs 1 Hold across the six institutions.
MSFT - Microsoft Corp.
Strongly bullish across covered banks; Wells Fargo holds the highest visible target among this set.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | - | 2026-04-28 | Reiterated rating. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Morgan Stanley | Overweight | - | 2026-01-29 | Reiterated rating. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| JP Morgan | Overweight | $550 | 2025-07-31 | Lower target $575 → $550. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Bank of America | Buy | $500 | 2026-03-09 | Initiated coverage Buy with $500 PT. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Citigroup | Market Outperform | - | 2026-06-01 | Initiated coverage. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Wells Fargo | Overweight | $650 | 2026-06-01 | Boost target $625 → $650. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
Consensus View - Rating: Buy, Target Price: $566.67 - Average of BAC, JPM, WFC targets; others not disclosed on-source.
GOOGL - Alphabet Inc. (Class A)
Broadly positive; multiple recent boosts in late April–June 2026, with Wells Fargo trimming slightly on June 30.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $450 | 2026-04-30 | Boost target $400 → $450. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Morgan Stanley | Overweight | $415 | 2026-06-22 | Reiterated Overweight; prior update lowered target to ~$416 on 2026-06-30. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| JP Morgan | Buy | - | 2026-05-04 | Reiterated rating. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Bank of America | Buy | $430 | 2026-04-30 | Boost target $370 → $430. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Citigroup | Outperform | - | 2026-05-04 | Reiterated rating. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Wells Fargo | Overweight | $416 | 2026-06-30 | Lower target $435 → $416. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
Consensus View - Rating: Buy, Target Price: $427.75 - Average across the four banks with disclosed targets.
AMZN - Amazon.com Inc.
All six cover; several target increases around April–July 2026; Goldman most recent with Buy $335 on July 8, 2026.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $335 | 2026-07-08 | Reiterated rating with $335 PT. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Morgan Stanley | Overweight | $330 | 2026-04-30 | Boost target $300 → $330. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| JP Morgan | Buy | - | 2026-06-18 | Reiterated rating (target not shown on-source). | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Bank of America | Buy | $310 | 2026-04-30 | Boost target $298 → $310. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Citigroup | Market Outperform | - | 2026-05-29 | Reiterated rating (no PT shown). | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Wells Fargo | Overweight | $313 | 2026-06-26 | Reiterated rating; PT ticked to $313. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
Consensus View - Rating: Buy, Target Price: $322.00 - Average of GS, MS, BAC, WFC targets.
NVDA - NVIDIA Corp.
Cluster of target hikes around May 21, 2026 across the banks; stance remains broadly Buy/Overweight.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $285 | 2026-05-19 | Reiterated rating; PT raised $250 → $285. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Morgan Stanley | Overweight | $288 | 2026-05-21 | Set target $285 → $288. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| JP Morgan | Overweight | $280 | 2026-05-21 | Boost target $265 → $280. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Bank of America | Buy | $350 | 2026-05-21 | Reiterated rating; PT $320 → $350. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Citigroup | Buy | - | 2026-02-26 | Initiated coverage Buy (no PT shown on-source). | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Wells Fargo | Overweight | $315 | 2026-04-15 | Reiterated rating; PT $265 → $315. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
Consensus View - Rating: Buy, Target Price: $303.60 - Average across 5 banks with disclosed PTs (GS, MS, JPM, BAC, WFC).
META - Meta Platforms Inc.
Mixed adjustments this spring: MS and BAC trimmed targets but remain Overweight/Buy; others in this set lack recent public PTs on-source.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | Coverage listed on-source, latest actionable line not visible. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Morgan Stanley | Overweight | $775 | 2026-03-18 | Lower target $825 → $775. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| JP Morgan | - | - | - | Brokerage listed; latest detailed line not shown on-source. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Bank of America | Buy | $820 | 2026-04-10 | Lower target $885 → $820. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Citigroup | Outperform | - | 2026-01-29 | Reiterated rating (no PT shown). | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Wells Fargo | - | - | - | Brokerage listed; latest detailed line not shown on-source. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
Consensus View - Rating: Buy, Target Price: $797.50 - Average of MS and BAC targets; limited disclosure for others on-source.
TSLA - Tesla Inc.
Signals are mixed across the six: GS moved to Buy in June; MS is Equal Weight; WFC remains Underweight with a much lower PT; BAC initiated Buy with $460.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | - | 2026-06-05 | Initiated/shifted to Buy. | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Morgan Stanley | Equal Weight | $415 | 2026-07-02 | Reiterated Equal Weight with $415 PT. | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| JP Morgan | Neutral | - | 2026-06-22 | Reiterated Neutral. | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Bank of America | Buy | $460 | 2026-02-11 | Initiated coverage Buy with $460 PT. | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Citigroup | Market Perform | - | 2026-07-09 | Initiated Market Perform. | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
| Wells Fargo | Underweight | $125 | 2026-01-06 | Lower target $130 → $125. | https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/ |
Consensus View - Rating: Hold, Target Price: $333.33 - Mixed: 2 Buy, 3 Hold/Neutral, 1 Underweight (Sell-equivalent).
AVGO - Broadcom Inc.
June 4, 2026 saw a wave of raises/updates across multiple banks; overall stance remains Buy/Overweight.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $525 | 2026-06-04 | Reiterated rating with $525 PT. | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Morgan Stanley | Overweight | $502 | 2026-06-04 | Set target $485 → $502. | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| JP Morgan | Overweight | $580 | 2026-06-04 | Boost target $500 → $580. | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Bank of America | Buy | $530 | 2026-06-04 | Boost target $450 → $530. | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Citigroup | Buy | - | 2026-06-04 | Reiterated rating (no PT shown). | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
| Wells Fargo | - | - | - | No visible recent entry on-source. | https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/ |
Consensus View - Rating: Buy, Target Price: $534.25 - Average across GS, MS, JPM, BAC targets.
TSM - Taiwan Semiconductor Manufacturing Co. Ltd.
Two of the six (BAC, Citi) show recent actions; BAC lifted PT sharply to $590 on June 22, 2026.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | No recent public action visible on-source. | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Morgan Stanley | - | - | - | No recent public action visible on-source. | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| JP Morgan | - | - | - | No recent public action visible on-source. | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Bank of America | Buy | $590 | 2026-06-22 | Boost target $490 → $590. | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Citigroup | Buy | - | 2026-07-06 | Reiterated rating (no PT shown). | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
| Wells Fargo | - | - | - | No recent public action visible on-source. | https://www.marketbeat.com/stocks/NYSE/TSM/forecast/ |
Consensus View - Rating: Buy, Target Price: $590.00 - Only BAC disclosed a PT among the six; Citi rating supports positive skew.
Highlights
- AAPL: Bank of America cut Apple to Hold with a $315 target on June 18, 2026; JPM and WFC remain Overweight with $325/$310 targets.
- MSFT: Wells Fargo lifted its PT to $650 on June 1, 2026; BAC initiated at Buy with $500 on March 9, 2026.
- GOOGL: Goldman raised to $450 and BofA to $430 on April 30, 2026; Wells Fargo trimmed to $416 on June 30, 2026.
- AMZN: Goldman reiterated Buy with a $335 PT on July 8, 2026; Morgan Stanley boosted to $330 on April 30, 2026.
- NVDA: Clustered May 21, 2026 raises across MS, JPM, BAC; BAC highest among these at $350.
- META: MS cut PT to $775 (Mar 18, 2026) and BAC to $820 (Apr 10, 2026) while maintaining Overweight/Buy.
- TSLA: Mixed—Goldman to Buy (Jun 5, 2026); MS Equal Weight $415 (Jul 2, 2026); WFC Underweight $125 (Jan 6, 2026); BAC Buy $460 (Feb 11, 2026).
- AVGO: Broad-based June 4, 2026 target increases—JPM to $580; GS to $525; BAC to $530; MS to $502.
- TSM: BAC raised PT to $590 on June 22, 2026; Citi reiterated Buy July 6, 2026.
Notes: Where MarketBeat’s page did not display a bank’s explicit target or action line in the public view, fields are left null. Consensus target is a simple average of the available targets across the specified six institutions only, not the full Street consensus.
IPO Calendar
Timeframe: July 10, 2026 – August 10, 2026 (U.S. equity markets)
IPO activity in mid‑July is led by a very large cross‑listing (SK hynix ADRs) alongside traditional IPOs across data center infrastructure (Csquare), advanced nuclear fuel (Standard Nuclear), and biotech (Tarsier). The pipeline remains active following a record first half for new listings, though most issuers continue to target narrow windows and may finalize terms close to pricing. Renaissance Capital and exchange data point to a strong backlog, with June/early July seeing elevated filing and pricing activity. (nasdaq.com)
SK hynix Inc. (American Depositary Shares) (SKHY)
- Expected listing date: 2026-07-10
- Exchange: Nasdaq Global Select Market
- Business summary: South Korea–based SK hynix is one of the world’s largest memory semiconductor manufacturers (DRAM, NAND, and HBM used in AI systems). The company is listing ADRs in the U.S.; its Form F‑1 notes each ADR represents one‑tenth of a common share. Proceeds are intended to support capacity expansion for advanced memory tied to AI demand. (sec.gov)
- Notes: Expected first trade date is Friday, July 10, 2026; Nasdaq Trader indicates when‑issued trading under SKHYV prior to regular settlement. Final ADR pricing and size were not confirmed as of July 10. FTSE Russell and AP News also flagged the July 10 commencement of ADR trading. Treat all terms as tentative until the final prospectus is filed. (nasdaqtrader.com)
- Sources: SEC EDGAR: SK hynix Inc. F‑1/A index (Accession 0001193125-26-280172), Nasdaq Trader Equity Trader Alert #2026‑37 (SKHYV when‑issued), AP News: “SK Hynix hits the U.S. stock market…” (July 10, 2026), Axios: “SK Hynix plans $28 billion stock offering” (July 8, 2026), FTSE Russell Index Notice: Treatment of SK hynix ADS Listing (July 2026)
Csquare, Inc. (CSQR)
- Expected listing date: 2026-07-16
- Price range: $23 – $27
- Shares offered: 50,000,000 primary shares (plus over‑allotment, if any)
- Exchange: NYSE
- Lead underwriters: Morgan Stanley, TD Securities, Wells Fargo Securities, BofA Securities, BMO Capital Markets, Scotiabank
- Business summary: Dallas‑area (Coppell, TX) data center developer/operator focused on high‑density, energy‑efficient facilities supporting AI and cloud workloads; backed by Brookfield Infrastructure. The issuer publicly filed its S‑1 and has set proposed terms to sell 50 million shares. (streetinsider.com)
- Notes: Issuer indicates intent to list on the NYSE under “CSQR.” Morgan Stanley and TD Securities named as lead bookrunners in draft underwriting agreement; other joint bookrunners disclosed in third‑party deal trackers. All terms remain subject to change until pricing. (sec.gov)
- Sources: SEC EDGAR: Csquare, Inc. S‑1/A index (Accession 0001104659-26-080556; filed July 6, 2026), Business Wire: “Csquare, Inc. Files Registration Statement…” (June 16, 2026), Axios Pro Rata (terms summary; July 6–7, 2026), Justia Contracts: Csquare Underwriting Agreement (identifies Morgan Stanley & TD Securities), IPOGrid: Csquare filing profile (exchange/underwriters context)
Standard Nuclear, Inc. (STDN)
- Expected listing date: 2026-07-16
- Price range: $18 – $21
- Shares offered: 18,250,000 Class A shares (plus 2,737,500 over‑allotment)
- Exchange: NYSE
- Lead underwriters: BofA Securities, Goldman Sachs & Co. LLC, Barclays, UBS Investment Bank
- Business summary: Advanced nuclear fuel manufacturer focused on TRISO fuel and related radioisotope power systems for next‑generation and small modular reactors; S‑1 indicates industrial‑scale TRISO production capability in the U.S. (sec.gov)
- Notes: Reuters reported NYSE listing under “STDN” with BofA, Goldman Sachs, Barclays and UBS among underwriters; Axios and Benzinga calendars indicated a July 16 pricing/launch window and an $18–$21 range. Final terms and timing remain contingent on market conditions. (investing.com)
- Sources: SEC EDGAR: Standard Nuclear, Inc. S‑1/A excerpts (share count/operations), Reuters: “Standard Nuclear eyes up to $3.55B valuation in U.S. IPO” (July 7, 2026), Axios Pro Rata (terms summary; July 7, 2026), Benzinga IPO Calendar (date/range reference), StockAnalysis: STDN company page (estimated IPO date)
Tarsier Pharma Ltd. (TARX)
- Expected listing date: 2026-07-15
- Price range: $8 – $10
- Shares offered: 5,000,000 ordinary shares
- Exchange: NYSE American
- Lead underwriters: Konik Capital Partners, LLC (division of T.R. Winston)
- Business summary: Israel‑based late‑stage ophthalmic biopharma developing TRS01 for non‑infectious anterior uveitis (including uveitic glaucoma) and additional inflammatory eye diseases. The company filed an F‑1/A and applied to list on NYSE American as “TARX.” (sec.gov)
- Notes: Lead underwriter identified in the filed underwriting agreement as Konik Capital Partners (T.R. Winston). Biotech trackers and calendars indicate a proposed 5.0M share deal at $8–$10 for the week of July 15; timing and terms may change pending the final prospectus. (sec.gov)
- Sources: SEC EDGAR: Tarsier Pharma Ltd. F‑1/A index (June 16, 2026), SEC EDGAR: Tarsier underwriting agreement (Konik Capital Partners), Company disclosure: applied to list on NYSE American as “TARX”, BioBucks 2026 Biotech IPO tracker (terms/timing reference), Benzinga IPO Calendar (date/range reference)
Syntiant Corp. (SYTN)
- Exchange: Nasdaq (proposed)
- Business summary: Irvine, CA–based fabless semiconductor company developing ultra‑low‑power AI processors and software for edge inference (speech/audio/vision). The company publicly filed an S‑1 on July 6 and intends to list on Nasdaq as “SYTN.” (globenewswire.com)
- Notes: Filed for an IPO and announced a proposed Nasdaq listing; no pricing date/range had been set as of July 10, 2026. Inclusion here as an expected offering within the coming month is subject to market window and roadshow progress. (globenewswire.com)
- Sources: GlobeNewswire: Syntiant publicly files S‑1; intends to list on Nasdaq as SYTN (July 6, 2026), Reuters via Fidelity: Syntiant files for U.S. IPO; plans Nasdaq listing (July 6, 2026)
IPO calendars are fluid. Dates, exchanges, tickers, share counts, price ranges, and underwriter lineups can change up to pricing. Always confirm final details in the effective prospectus (SEC Rule 424(b) filing) and issuer/exchange notices on or after pricing/trade date. Where primary filings were inaccessible via the tool, we corroborated terms with reputable secondary sources and flagged uncertainties in Notes.
Sources
- Stock Ratings: https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/, https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/, https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/META/forecast/, https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/, https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/, https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/, https://www.marketbeat.com/stocks/NYSE/TSM/forecast/
- IPO Calendar: https://www.globenewswire.com/news-release/2026/07/06/3322790/0/en/syntiant-publicly-files-registration-statement-for-proposed-initial-public-offering.html?utm_source=openai, https://www.investing.com/news/stock-market-news/nuclear-fuel-firm-standard-nuclear-eyes-up-to-355-billion-valuation-in-us-ipo-4779014?utm_source=openai, https://www.nasdaq.com/press-release/nasdaq-delivers-strongest-first-half-us-exchange-history-public-markets-momentum?utm_source=openai, https://www.nasdaqtrader.com/TraderNews.aspx?id=ETA2026-37&utm_source=openai, https://www.sec.gov/Archives/edgar/data/2086716/000121390026075742/ea0276071-11.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2102720/000121390026066188/ea027016609ex1-1.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2102720/000121390026069143/0001213900-26-069143-index.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2105398/000110465926080556/0001104659-26-080556-index.htm, https://www.sec.gov/Archives/edgar/data/2120882/000119312526280172/0001193125-26-280172-index.htm?utm_source=openai, https://www.streetinsider.com/Business%2BWire/Csquare%2C%2BInc.%2BFiles%2BRegistration%2BStatement%2Bfor%2BProposed%2BInitial%2BPublic%2BOffering/26655442.html?classic=1&utm_source=openai
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2026-07-10 at 12:39 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI